These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
63 related items for PubMed ID: 3737270
1. Relationship between serum concentration and daily dose of dantrolene in cerebral palsy patients. Inotsume N, Higashi A, Matsukane I, Chikazawa S, Nakano M, Matsuda I. Pediatr Pharmacol (New York); 1986; 5(4):253-9. PubMed ID: 3737270 [Abstract] [Full Text] [Related]
3. Pharmacokinetics of intravenously administered dantrolene and its 5-hydroxy metabolite in dogs. Wuis EW, Vree TB, Van Der Kleijn E. Int J Clin Pharmacol Res; 1990 Aug; 10(4):203-10. PubMed ID: 2079379 [Abstract] [Full Text] [Related]
5. Dantrolene sodium suspension in treatment of spastic cerebral palsy. Joynt RL, Leonard JA. Dev Med Child Neurol; 1980 Dec; 22(6):755-67. PubMed ID: 7004956 [Abstract] [Full Text] [Related]
6. Pharmacology of dantrolene sodium in children. Lietman PS, Haslam RH, Walcher JR. Arch Phys Med Rehabil; 1974 Aug; 55(8):388-92. PubMed ID: 4853611 [No Abstract] [Full Text] [Related]
7. Dantrolene sodium: long-term effects in severe spasticity. Chyatte SB, Basmajian JV. Arch Phys Med Rehabil; 1973 Jul; 54(7):311-5. PubMed ID: 4577936 [No Abstract] [Full Text] [Related]
8. [Phenytoin kinetics in toxic serum levels]. Beier R, Zschiesche M, Franke G. Psychiatr Neurol Med Psychol (Leipz); 1983 Aug; 35(8):471-8. PubMed ID: 6635035 [Abstract] [Full Text] [Related]
9. Long-term use of botulinum toxin type A in children with cerebral palsy: treatment consistency. Molenaers G, Schörkhuber V, Fagard K, Van Campenhout A, De Cat J, Pauwels P, Ortibus E, De Cock P, Desloovere K. Eur J Paediatr Neurol; 2009 Sep; 13(5):421-9. PubMed ID: 18977158 [Abstract] [Full Text] [Related]
16. Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study. Plotkin H, Coughlin S, Kreikemeier R, Heldt K, Bruzoni M, Lerner G. Dev Med Child Neurol; 2006 Sep; 48(9):709-12. PubMed ID: 16904014 [Abstract] [Full Text] [Related]
17. Safety of low-dose oral dantrolene sodium on hepatic function. Kim JY, Chun S, Bang MS, Shin HI, Lee SU. Arch Phys Med Rehabil; 2011 Sep; 92(9):1359-63. PubMed ID: 21878205 [Abstract] [Full Text] [Related]